84. Sarcoidosis Clinical trials / Disease details
Clinical trials : 149 / Drugs : 227 - (DrugBank : 81) / Drug target genes : 82 - Drug target pathways : 167
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03561025 (ClinicalTrials.gov) | October 1, 2018 | 6/6/2018 | Diagnostic Potential of PET/MRI in Cardiac Sarcoidosis | Diagnostic Potential of PET/MRI in Cardiac Sarcoidosis: A Pilot Study Combining Advanced MRI and 18F-FDG and 18F-GE180 PET of the Myocardium | Sarcoidosis;Cardiomyopathies | Diagnostic Test: 18F-FDG-PET/MRI;Diagnostic Test: 18F-GE180-PET/MRI | St. Olavs Hospital | Norwegian University of Science and Technology;University Hospital, Essen | Completed | 18 Years | N/A | All | 33 | N/A | Norway |